BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34638814)

  • 1. The Ephb2 Receptor Uses Homotypic, Head-to-Tail Interactions within Its Ectodomain as an Autoinhibitory Control Mechanism.
    Xu Y; Robev D; Saha N; Wang B; Dalva MB; Xu K; Himanen JP; Nikolov DB
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homotypic receptor-receptor interactions regulating Eph signaling.
    Nikolov DB; Xu K; Himanen JP
    Cell Adh Migr; 2014; 8(4):360-5. PubMed ID: 25530219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Shb scaffold binds the Nck adaptor protein, p120 RasGAP, and Chimaerins and thereby facilitates heterotypic cell segregation by the receptor EphB2.
    Wagner MJ; Hsiung MS; Gish GD; Bagshaw RD; Doodnauth SA; Soliman MA; Jørgensen C; Tucholska M; Rottapel R
    J Biol Chem; 2020 Mar; 295(12):3932-3944. PubMed ID: 32060095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the ligand-binding domain of the EphB2 receptor at 2 A resolution.
    Goldgur Y; Paavilainen S; Nikolov D; Himanen JP
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Feb; 65(Pt 2):71-4. PubMed ID: 19193989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling.
    Himanen JP; Chumley MJ; Lackmann M; Li C; Barton WA; Jeffrey PD; Vearing C; Geleick D; Feldheim DA; Boyd AW; Henkemeyer M; Nikolov DB
    Nat Neurosci; 2004 May; 7(5):501-9. PubMed ID: 15107857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of the EphB6 receptor ectodomain.
    Mason EO; Goldgur Y; Robev D; Freywald A; Nikolov DB; Himanen JP
    PLoS One; 2021; 16(3):e0247335. PubMed ID: 33770085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of an Eph receptor-ephrin complex.
    Himanen JP; Rajashankar KR; Lackmann M; Cowan CA; Henkemeyer M; Nikolov DB
    Nature; 2001 Dec 20-27; 414(6866):933-8. PubMed ID: 11780069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectodomain structures of Eph receptors.
    Himanen JP
    Semin Cell Dev Biol; 2012 Feb; 23(1):35-42. PubMed ID: 22044883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition.
    Chrencik JE; Brooun A; Recht MI; Nicola G; Davis LK; Abagyan R; Widmer H; Pasquale EB; Kuhn P
    J Biol Chem; 2007 Dec; 282(50):36505-13. PubMed ID: 17897949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5.
    Xu K; Tzvetkova-Robev D; Xu Y; Goldgur Y; Chan YP; Himanen JP; Nikolov DB
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14634-9. PubMed ID: 23959867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2.
    Himanen JP; Henkemeyer M; Nikolov DB
    Nature; 1998 Dec; 396(6710):486-91. PubMed ID: 9853759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tiam-Rac signaling mediates trans-endocytosis of ephrin receptor EphB2 and is important for cell repulsion.
    Gaitanos TN; Koerner J; Klein R
    J Cell Biol; 2016 Sep; 214(6):735-52. PubMed ID: 27597758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Eph tyrosine kinase receptors EphB2 and EphA2 are novel proteolytic substrates of tissue factor/coagulation factor VIIa.
    Eriksson O; Ramström M; Hörnaeus K; Bergquist J; Mokhtari D; Siegbahn A
    J Biol Chem; 2014 Nov; 289(47):32379-91. PubMed ID: 25281742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eph/ephrin reverse signalling induces axonal retraction through RhoA/ROCK pathway.
    Takeuchi S; Katoh H; Negishi M
    J Biochem; 2015 Sep; 158(3):245-52. PubMed ID: 25922200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiation.
    Nikolov DB; Xu K; Himanen JP
    Biochim Biophys Acta; 2013 Oct; 1834(10):2160-5. PubMed ID: 23628727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eph receptors and ephrins restrict cell intermingling and communication.
    Mellitzer G; Xu Q; Wilkinson DG
    Nature; 1999 Jul; 400(6739):77-81. PubMed ID: 10403252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EphB2 regulates contact-dependent and contact-independent signaling to control platelet function.
    Vaiyapuri S; Sage T; Rana RH; Schenk MP; Ali MS; Unsworth AJ; Jones CI; Stainer AR; Kriek N; Moraes LA; Gibbins JM
    Blood; 2015 Jan; 125(4):720-30. PubMed ID: 25370417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Manipulation of EphB2 regulatory motifs and SH2 binding sites switches MAPK signaling and biological activity.
    Tong J; Elowe S; Nash P; Pawson T
    J Biol Chem; 2003 Feb; 278(8):6111-9. PubMed ID: 12486127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent roles for Eph and ephrin in avian cranial neural crest.
    Mellott DO; Burke RD
    BMC Dev Biol; 2008 May; 8():56. PubMed ID: 18495033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Value of EphB2 Receptor and Cognate Ephrin Ligands in Prognostic and Predictive Assessments of Human Breast Cancer.
    Ebrahim AS; Hailat Z; Bandyopadhyay S; Neill D; Kandouz M
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.